Using Six Sigma to improve once daily gentamicin dosing and therapeutic drug monitoring performance

BMJ Quality and Safety

Volumn 21, Issue 12, 2012, Pages 1042-1051

  Egan, Sean ^a   Murphy, Philip G ^a,b   Fennell, Jerome P ^a   Kelly, Sinead ^a   Hickey, Mary ^a   McLean, Carolyn ^a   Pate, Muriel ^a   Kirke, Ciara ^a   Whiriskey, Annette ^a   Wall, Niall ^a   McCullagh, Eddie ^a   Murphy, Joan ^a   Delaney, Tim ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN;

ACCURACY; ARTICLE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG MONITORING; HEALTH CARE QUALITY; HUMAN; MEDICAL AUDIT; MEDICAL PRACTICE; METHODOLOGY; PERFORMANCE MEASUREMENT SYSTEM; PRACTICE GUIDELINE; PROCESS DESIGN; ROOT CAUSE ANALYSIS; SIX SIGMA; STANDARDIZATION; TEACHING HOSPITAL; THERAPY DELAY; BLOOD; DRUG ADMINISTRATION; MEDICATION COMPLIANCE; PATIENT CARE; PROCEDURES; STANDARDS; TOTAL QUALITY MANAGEMENT;

CLINICAL AUDIT; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; GENTAMICINS; GUIDELINE ADHERENCE; HUMANS; MEDICATION ADHERENCE; PATIENT CARE TEAM; PROCESS ASSESSMENT (HEALTH CARE); QUALITY ASSURANCE, HEALTH CARE; TOTAL QUALITY MANAGEMENT;

EID: 84871935432     PISSN: 20445415     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmjqs-2012-000824     Document Type: Article

References (23)

1. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Disease Society of America. Clin Infect Dis 2009;48:1-12.
2. Patterson DL. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004;38(Suppl 4):S341-5.
3. Leong CL, Buising K, Richards M, et al. Providing guidelines and education is not enough; an audit of gentamicin use at The Royal Melbourne Hospital. Intern Med J 2006;36:37-42. (Pubitemid 43362545)
4. Saunders NJ, Adams DN, Lynn WA. A prospective laboratory-based audit of gentamicin therapeutic drug monitoring. J Antimicrob Chemother 1995;36:729-36.
5. Swan SK. Aminoglycoside nephrotoxicity. Semin Nephrol 1997;17:27-33. (Pubitemid 27045159)
6. Lerner SA, Schmitt BA, Seligsohn R, et al. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Am J Med 1986;80:98-104. (Pubitemid 16036773)
7. The National Patient Safety Agency, National Health Service, United Kingdom. Patient Safety Alert - Safer Use of Intravenous Gentamicin for Neonates. Ref Number 1085, 2010. http://www.nrls.npsa.nhs.uk/resources/? entryid45=66271&p=7 (accessed 13 Jun 2012).
8. Barry R. The Six Sigma Book for Healthcare. Chicago, IL: Health Administration Press, 2002.
9. Frankel HL, Crede WB, Topal JE, et al. Use of corporate six sigma performance-improvement strategies to reduce incidence of catheter-related bloodstream infection in a surgical ICU. J Am Coll Surg 2005;201:349-58. (Pubitemid 41206772)
10. Moorman DW. On the quest for Six Sigma. Am J Surg 2005;189:253-8. (Pubitemid 40431940)
11. Parker BM, Henderson JM, Vitagliano S, et al. Six sigma methodology can be used to improve adherence for antibiotic prophylaxis in patients undergoing non-cardiac surgery. Anest Analg 2007;140:140-6. (Pubitemid 46360436)
12. http://www.ge.com/sixsigma/makingcustomers.html (accessed May 2012).
13. Kashuba AD, Nafzinger AN, Drusano GL, et al. Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria. Antimicrob Agents Chemother 1999;43:623-9. (Pubitemid 29109529)
14. Gross AS. Best practice in therapeutic drug monitoring. Br J Clin Pharmacol 1998;46:95-9. (Pubitemid 28342778)
15. Nicolau DP, Freeman CD, Belliveau PP, et al. Experience with a once-daily aminoglycoside program administered to 2184 adult patients. Antimicrob Agents Chemother 1995;39:650-5.
16. Urban AW, Craig WA. Daily dosage of aminoglycosides. Curr Clin Top Infect Dis 1997;17:236-55. (Pubitemid 127674405)
17. Lovering AM, Reeves DS. Potentially dangerous misuse of the Hartford once-daily nomogram for gentamicin. J Antimicrob Chemother 2009;64:1117-18.
18. AHFS Drug information. The American Society of Health-System Pharmacists. 2009. Gentamicin monograph 8:12.02 Page 77-83.
19. Drusano GL, Ambrose PG, Bhavnani SM, et al. Back to the future: using aminoglycosides again and how to dose them optimally. Clin Infect Dis 2007;45:753-60. (Pubitemid 47378891)
20. Begg EJ, Barclay ML, Duffull SB. A suggested approach to once-daily aminoglycoside dosing. Br J Clin Pharmacol 1995;39:605-9.
21. Kirkpatrick CM, Duffull SB, Begg EJ. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily. Br J Clin Pharmacol 1999;47:637-43. (Pubitemid 29257661)
22. Pai MP, Bearden DT. Antimicrobial dosing considerations in obese adult patients. Pharmacotherapy 2007;27:1081-91.
23. Nolan T, Resar R, Haraden C, et al. Improving the Reliability of Health Care. Boston: Institute of Healthcare Improvement, 2004.